Peter Lynch · Growth at a reasonable price (GARP)
Is Apellis Pharmaceuticals, Inc. (APLS) a Peter Lynch Stock?
Strong GARP candidate: growth at a reasonable price.
77/100
Mixto
3/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a APLS
PEG ≤ 1.0
clave-
EPS CAGR ≥ 15%
clave-
Revenue CAGR ≥ 10%
97.1%
Net margin > 0
12.1%
Cómo se valora APLS en otras estrategias
Datos financieros en vivo
Cap. mercado
$5.25B
PER (TTM)
38.8x
ROIC (TTM)
18.11%
Margen bruto
90.12%
Otros análisis Peter Lynch
Preguntas frecuentes
What is APLS's Peter Lynch fit score?
APLS scores 77/100 on our Peter Lynch fit engine. Strong GARP candidate: growth at a reasonable price.
Does Peter Lynch actually own APLS?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends APLS.
How often is this score updated?
APLS's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende APLS personalmente.
